Home › Mieloma multiplo › Virginia › Arlington
Studi clinici su Mieloma multiplo a Arlington, VA
9 studi su Mieloma multiplo cercano partecipanti presso sedi a Arlington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
In reclutamentoFase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 278716, Fairfax · a 11 mi di distanza
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
In reclutamentoFase 2
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
In reclutamentoFase 1/2
- Research Site, Fairfax · a 11 mi di distanza
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
In reclutamentoFase 3
- Research Site, Fairfax · a 11 mi di distanza
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · a 11 mi di distanza
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
In reclutamentoFase 3
- GSK Investigational Site, Fairfax · a 11 mi di distanza
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
In reclutamentoFase 2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
In reclutamentoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
In reclutamentoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi di distanza
Studi su Mieloma multiplo in altre città
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Altri studi a Arlington
- Cancro del polmone non a piccole cellule104 studi
- Cancro metastatico53 studi
- Cancro colorettale52 studi
- Cancro (tutti i tipi)48 studi
- Cancro al seno46 studi
- Cancro ovarico46 studi
- Cancro ai polmoni41 studi
- Cancro dell'endometrio39 studi
- Cancro pancreatico33 studi
- Carcinoma a cellule squamose della testa e del collo26 studi
- Carcinoma polmonare a piccole cellule23 studi
- Cancro al seno triplo negativo20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.